Researchers from the Oxford Vaccine Group administered the dose in the first clinical trial of a vaccine targeting the Bundibugyo ebolavirus.
University of Oxford vaccinates first participant in world-first trial
Researchers from the Oxford Vaccine Group administered the dose in the first clinical trial of a vaccine targeting the Bundibugyo ebolavirus.